Pingping Qu is a notable inventor based in Little Rock, AR (US). She has made significant contributions to the field of medical research, particularly in the area of multiple myeloma. With a total of 3 patents, her work has the potential to impact the lives of many patients.

Latest Patents

One of her latest patents is the GEP5 model for multiple myeloma. This invention provides methods for prognosing a subject with, or suspected of having, multiple myeloma. The methods involve testing the gene expression levels of enolase 1 (ENO1), fatty acid binding protein 5 (FABP5), thyroid hormone receptor interactor 13 (TRIP13), transgelin 2 (TAGLN2), and replication factor C (activator 1) 4 (RFC4) in a biological sample isolated from the subject. Additionally, the invention offers methods of treatment for multiple myeloma, along with kits, oligonucleotides, and systems for performing the methods provided.

Career Highlights

Pingping Qu is currently associated with Bioventures, LLC, where she continues her innovative work. Her research focuses on advancing the understanding and treatment of multiple myeloma, contributing to the broader field of oncology.

Collaborations

She has collaborated with esteemed colleagues such as Bart Barlogie and Christoph Heuck, further enhancing her research and development efforts.

Conclusion

Pingping Qu's contributions to the field of medical research, particularly in multiple myeloma, highlight her innovative spirit and dedication to improving patient outcomes. Her work exemplifies the impact that dedicated inventors can have on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.